Table 5. Comparison of secondary outcomes at 3-month follow-up.
| Outcomes | MBCT-HeLM (N= 11) |
MBSR (N= 10) |
TAU (N= 8) |
MBCT-HeLM vs. MBSR | MBCT-HeLM vs. TAU | ||
|---|---|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Mean (SD) | Mean diff. | 95 % CI | Mean diff. | 95 % CI | |
| Blood pressure | |||||||
| Systolic blood pressure (mmHg) | 122.6 (16.3) | 130.4 (14.1) | 127.8 (14.8) | -7.8 | -26.4 to 10.8 | -5.2 | -24.3 to 13.9 |
| Diastolic blood pressure (mmHg) | 65 (20.5) | 73 (15.2) | 70.7(9.6) | -8.0 | -29.9 to 13.9 | -5.7 | -24.8 to 13.4 |
| GAD-7 | 3.2 (2.4) | 3.5 (1.6) | 8.0 (5.0) | -0.3 | -2.4 to 1.8 | -4.8 | -8.6 to -0.9 |
| CAQ* | 16.6 (10) | 23.0 (4.9) | 30.0 (6.2) | -6.3 | -17.5 to 4.8 | -13.3 | -26.4 to -0.2 |
| RAND 36-Item Health Survey 1.0 | |||||||
| RAND 36-Item Physical | 51.6 (21.4) | 59.1 (24.4) | 54.9 (32.4) | -7.5 | -29.0 to 14.0 | -3.3 | -32.1 to 25.7 |
| RAND 36-Item Psychological | 63.8 (18.2) | 61.3 (18.3) | 51.6 (20.9) | 2.5 | -14.8 to 19.8 | 12.1 | -6.9 to 31.2 |
| FFMQ (Total) | 125 (19.0) | 131 (26.4) | 115 (14.6) | -6.0 | -28.0 to 14.8 | 10.0 | -7.3 to 26.7 |
| SCS (Total) | 2.8 (.51) | 2.9 (0.69) | 2.7 (0.6) | -0.1 | -0.8 to 0.4 | 0.1 | -0.1 to 1.0 |
| PANAS-Positive | 27.9 (6.1) | 32.1 (9.8) | 28.3 (9.9) | -4.2 | -11.8 to 3.4 | -0.4 | -8.2 to 7.3 |
| PANAS-Negative | 18.6 (7.4) | 18.8 (7.7) | 17.3 (9.6) | -0.2 | -7.9 to 6.4 | 0.8 | -7.4 to 9.0 |
| IPQ-R | |||||||
| IPQ-R timeline acute/chronic | 21.3 (5.5) | 23.8 (4.1) | 26.7 (3.5) | -2.6 | -7.5 to 2.3 | -5.5 | -10.2 to -0.7 |
| IPQ-R timeline cyclical | 11.5 (3.7) | 10.0 (3.7) | 11.4 (4.7) | 1.5 | -2.1 to 5.2 | 0.2 | -3.9 to 4.2 |
| IPQ-R consequences | 18.3 (4.9) | 20.4 (5.8) | 20.6 (5.6) | -2.1 | -7.3 to 3.1 | -2.4 | -7.4 to 2.7 |
| IPQ-R personal control | 22.1 (3.5) | 23.5 (3.6) | 21.6 (4.4) | -1.4 | -4.9 to 2.1 | 0.5 | -3.4 to 4.3 |
| IPQ-R treatment control | 17.0 (2.6) | 17.3 (2.9) | 19.0 (2.7) | -0.3 | -3.0 to 2.5 | -2.0 | -4.6 to 0.6 |
| IPQ-R illness coherence | 19.3 (4.0) | 18.1 (5.1) | 20.0 (4.3) | 1.1 | -3.2 to 5.5 | -0.7 | -4.7 to 3.2 |
| IPQ-R emotional representations | 17.9 (4.8) | 18.6 (6.1) | 17.8 (6.1) | -0.7 | -6.0 to 4.6 | 0.1 | -5.1 to 5.4 |
| SAQ** | |||||||
| SAQ- physical limitations | 46.6 (14.2) | 43.5 (19.5) | 48.1 (19.5) | 3.1 | -18.9 to 25.1 | -1.5 | -28.1 to 25.1 |
| SAQ- angina stability | 63.3 (15.0) | 50.0 (24.5) | 40.0 (17.0) | 13.3 | -12.8 to 39.5 | 23.3 | -4.1 to 50.8 |
| SAQ- angina frequency | 72.2 (10.0) | 66.6 (11.7) | 75.0 (11.7) | 5.6 | -8.6 to 19.7 | -2.8 | -23.5 to 17.9 |
| SAQ- treatment satisfaction | 63.4 (8.8) | 62.6 (11.0) | 64.2 (16.8) | 0.8 | -12.1 to 13.7 | -0.8 | -22.0 to 20.4 |
| SAQ- disease perception | 56.6 (13.1) | 51.1 (19.6) | 46.0 (28.2) | 5.6 | -15.9 to 27.1 | 10.0 | -23.3 to 43.3 |
Note: TAU: Treatment As Usual; SD: Standard Deviation; CI: Confidence Intervals; GAD-7: Generalised Anxiety Questionnaire-7; CAQ: Cardiac Anxiety Questionnaire; FFMQ: Five Facet Mindfulness Questionnaire; SCS: Self-Compassion Scale; PANAS: Positive and Negative Affect Scale; IPQ-R: Illness Perception Questionnaire-Revised. SAQ: Seattle Angina Questionnaire;
*
CAQ was completed by participants with heart conditions only (MBCT, n=6; MBSR, n=5; TAU, n=3);
**
SAQ was completed by participants with heart conditions only (MBCT, n=6; MBSR, n=5; TAU, n=4).